🚨 M&A alert: Drug makers facing patent cliffs (i.e Keytruda by Merck or Stelara by J&J) will look to shore up revenues this year. We can expect dozens of M&A announcements and an interesting look at where biotech might go next regarding breakthrough treatments and cures.